Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry

BACKGROUND AND OBJECTIVE: Gastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF treatment guidelines suggest that all patients with IPF be considered for antacid therapy. However, emerging evidence sugges...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Pulm Med
Asıl Yazarlar: Jo, Helen E., Corte, Tamera J., Glaspole, Ian, Grainge, Christopher, Hopkins, Peter M. A., Moodley, Yuben, Reynolds, Paul N., Chapman, Sally, Walters, E. Haydn, Zappala, Christopher, Allan, Heather, Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, Macansh, Sacha, Goh, Nicole S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499965/
https://ncbi.nlm.nih.gov/pubmed/31053121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0846-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller